Skip navigation

Mitigate Compliance Risk and Improve Operational Efficiency to Streamline End-to-End Processes

October 16-17, 2019
  • Philadelphia, PA

Now in its 3rd year, CBI’s Managing HCP Interactions continues to emphasize the importance of streamlining the communication, engagement and management between the life sciences industry and HCPs. This must-attend meeting provides value-added open discussions with industry peers and proven strategies to improve the effectiveness and compliance of healthcare provider interactions.

HCP SPOTLIGHT: Tools and Tips for Industry to Partner with HCPs —
An HCP’s Perspective

Matthew Mintz, MD, FACP                     
Internal Medicine and Primary Care; Clinical Associate Professor
The George Washington University School of Medicine

BENCHMARK WITH INDUSTRY PEERS
ON CRITICAL TOPICS:

  • Establish a comprehensive and regulatory framework to successfully manage all HCP interactions
  • Examine how to identify company policies and work in
    cross-functional teams regarding thresholds/meal caps and other HCP costs
  • Brainstorm how to ease the contracting process internally
    and externally with HCPs
  • Discover real-world examples of valid FMV exceptions and the consistent use of FMV
  • Explore strategies for efficient cross-border management
  • Discuss the cultural differences to be aware of when working in multiple regions
  • Consider changes to systems, processes and policies and gain commitment from leadership ahead of specific requirements

Previous Attendee Acclaim:

Definitely a worth-while conference to attend.
Great knowledge sharing for both the
Medical Device and Pharmaceutical.

Senior Manager, Ethical Compliance, Varian Medical Systems

Valuable content overall and I learned some
useful tidbits I can use right away.

Medical Science Liaison, Vertex Pharmaceuticals

Great Information exchange!

Head of Global HCP Capabilities, Bristol-Myers Squibb

Conference was very well in level setting our understanding of the bigger picture.

Global Head, Compliance & Ethics Operations, Alexion Pharmaceuticals

Managing HCP Interactions

Mitigate Compliance Risk and Improve Operational Efficiency to Streamline End-to-End Processes

Now in its 3rd year, CBI’s Managing HCP Interactions continues to emphasize the importance of streamlining the communication, engagement and management between the life sciences industry and HCPs. This must-attend meeting provides value-added open discussions with industry peers and proven strategies to improve the effectiveness and compliance of healthcare provider interactions.

HCP SPOTLIGHT: Tools and Tips for Industry to Partner with HCPs —
An HCP’s Perspective

Matthew Mintz, MD, FACP                     
Internal Medicine and Primary Care; Clinical Associate Professor
The George Washington University School of Medicine

BENCHMARK WITH INDUSTRY PEERS
ON CRITICAL TOPICS:

  • Establish a comprehensive and regulatory framework to successfully manage all HCP interactions
  • Examine how to identify company policies and work in
    cross-functional teams regarding thresholds/meal caps and other HCP costs
  • Brainstorm how to ease the contracting process internally
    and externally with HCPs
  • Discover real-world examples of valid FMV exceptions and the consistent use of FMV
  • Explore strategies for efficient cross-border management
  • Discuss the cultural differences to be aware of when working in multiple regions
  • Consider changes to systems, processes and policies and gain commitment from leadership ahead of specific requirements

Previous Attendee Acclaim:

Definitely a worth-while conference to attend.
Great knowledge sharing for both the
Medical Device and Pharmaceutical.

Senior Manager, Ethical Compliance, Varian Medical Systems

Valuable content overall and I learned some
useful tidbits I can use right away.

Medical Science Liaison, Vertex Pharmaceuticals

Great Information exchange!

Head of Global HCP Capabilities, Bristol-Myers Squibb

Conference was very well in level setting our understanding of the bigger picture.

Global Head, Compliance & Ethics Operations, Alexion Pharmaceuticals